Research Status of HPV and Cervical Cancer
DOI:
https://doi.org/10.54097/hset.v8i.1205Keywords:
HPV, Cervical Cancer, Infection.Abstract
Cervical cancer is a worldwide malignant tumors in gynecology, which does great harm to women's health. The pathogenesis of cervical cancer is mainly related to the persistent infection of high-risk HPV virus. This paper mainly studies the relationship between HPV and cervical cancer, and finds that there is a close relationship between them. The significance of our study of this subject is that it is now clear that cervical cancer is transmitted through viruses and vectors, which is a great discovery. In this way, many years before the occurrence of cervical cancer, there is enough opportunity to find it and eliminate it, which is a very great contribution, so many patients who should have cervical cancer have been blocked, ensuring the health of women to a great extent.
Downloads
References
Beutner, K., Becker, T. and Stone, K., (1991). Epidemiology of Human Papillomavirus Infections. Dermatologic Clinics, 9 (2), pp.211-218.https://pubmed.ncbi.nlm.nih.gov/1647901/
Handler, N., Handler, M., Majewski, S. and Schwartz, R., (2015). Human papillomavirus vaccine trials and tribulations. Journal of the American Academy of Dermatology, 73 (5), pp.759-767. https://linkinghub.elsevier.com/retrieve/pii/S0190962215017491
Hoory, T., Monie, A., Gravitt, P. and Wu, T., (2008). Molecular Epidemiology of Human Papillomavirus. Journal of the Formosan Medical Association, 107 (3), pp.198-217.
What is cervical cancer: Types of cervical cancer. American Cancer Society. (n.d.). Retrieved April 6, 2022, from https://www.cancer.org/cancer/cervical-cancer/about/what-is-cervical-cancer.html
Verywell Health. (2020, January 29). Know more. feel better. Verywell Health. Retrieved April 6, 2022, from https://www.verywellhealth.com/
McMurray, H. R., Nguyen, D., Westbrook, T. F., & McAnce, D. J. (2001, February). Biology of human papillomaviruses. International journal of experimental pathology. Retrieved April 6, 2022, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2517699/
Women's Healthcare: Why is it important? The Health Guide. (n.d.). Retrieved April 6, 2022, from https://thehealthblog-ph.site123.me/women-s-healthcare-why-is-it-important
Goldsmith MR; Bankhead CR; Kehoe ST; Marsh G; Austoker J; (n.d.). Information and cervical screening: A qualitative study of women's awareness, understanding and information needs about HPV. Journal of medical screening.
Okunade, K. S. (2020, July). Human papillomavirus and cervical cancer. Journal of obstetrics and gynaecology: the journal of the Institute of Obstetrics and Gynaecology
Zheng, Z.-M., & Baker, C. C. (2006, September 1). Papillomavirus genome structure, expression, and post-transcriptional regulation. Frontiers in bioscience: a journal and virtual library.
What is cervical cancer?: Types of cervical cancer. American Cancer Society. (n.d.). Retrieved April 23, 2022, from https://www.cancer.org/cancer/cervical-cancer/about/what-is-cervical-cancer.html
Burd, E. M. (2003, January). Human papillomavirus and cervical cancer. Clinical microbiology reviews. Retrieved April 13, 2022, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC145302/
Burd, E., (2003). Human Papillomavirus and Cervical Cancer. Clinical Microbiology Reviews, 16 (1), pp.1-17.
Bekmukhambetov, Yz., Balmagambetova, Sk., Jarkenov, Ta., Nurtayeva, Sm., Mukashev, Tz. and Koyshybaev, Ak., (2016). Distribution of High Risk Human Papillomavirus Types in Western Kazakhstan - Retrospective Analysis of PCR Data. Asian Pac J Cancer Prev, 17 (5), pp.2667-2672.http://journal.waocp.org/article_62694.html
Schiffman, M., Castle, P., Jeronimo, J., Rodriguez, A. and Wacholder, S., (2007). Human papillomavirus and cervical cancer. The Lancet, 370 (9590), pp.890-907.
Moscicki, A., Shiboski, S., Hills, N., Powell, K., Jay, N., Hanson, E., Miller, S., Canjura-Clayton, L., Farhat, S., Broering, J. and Darragh, T., (2004). Regression of low-grade squamous intra-epithelial lesions in young women. The Lancet, 364 (9446), pp.1678-1683.
Woodman, C., Collins, S. and Young, L., (2007). The natural history of cervical HPV infection: unresolved issues. Nature Reviews Cancer, 7 (1), pp.11-22.
Gregoire, L., Lawrence, W., Kukuruga, D., Eisenbrey, A. and Lancaster, W., (1994). Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. International Journal of Cancer, 57 (4), pp.504-507.
Helland, Å., Olsen, A., Gjøen, K., Akselsen, H., Sauer, T., Magnus, P., Børresen-Dale, A. and Rønningen, K., (1998). An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with theHLA-DQA1*0102-DQB1*0602 haplotype: A population-based case–control study of Norwegian women. International Journal of Cancer, 76 (1), pp.19-24.
Chen, D., Juko-Pecirep, I., Hammer, J., Ivansson, E., Enroth, S., Gustavsson, I., Feuk, L., Magnusson, P., McKay, J., Wilander, E. and Gyllensten, U., (2013). Genome-wide Association Study of Susceptibility Loci for Cervical Cancer. JNCI: Journal of the National Cancer Institute, 105 (9), pp.624-633.
Allemani, C., Weir, H., Carreira, H., Harewood, R., Spika, D., Wang, X., Bannon, F., Ahn, J., Johnson, C., Bonaventure, A., Marcos-Gragera, R., Stiller, C., Azevedo e Silva, G., Chen, W., Ogunbiyi, O., Rachet, B., Soeberg, M., You, H., Matsuda, T., Bielska-Lasota, M., Storm, H., Tucker, T. and Coleman, M., (2015). Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). The Lancet, 385 (9972), pp.977-1010.
Ding, D., Chiang, M., Lai, H., Hsiung, C., Hsieh, C. and Chu, T., (2009). Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia. European Journal of Obstetrics & Gynecology and Reproductive Biology, 147 (2), pp.215-220.
Mirabello, L., Sun, C., Ghosh, A., Rodriguez, A., Schiffman, M., Wentzensen, N., Hildesheim, A., Herrero, R., Wacholder, S., Lorincz, A. and Burk, R., (2012). Methylation of Human Papillomavirus Type 16 Genome and Risk of Cervical Precancer in a Costa Rican Population. JNCI: Journal of the National Cancer Institute, 104 (7), pp.556-565.
Nyulangone.org. 2022. Types of Human Papillomavirus. [online] Available at: https://nyulangone.org/conditions/human-papillomavirus-in-adults/types
Plannedparenthood.org. 2022. What Is HPV & How Do You Get It?. [online] Available at: https://www.plannedparenthood.org/learn/stds-hiv-safer-sex/hpv
Verywell Health. 2022. Causes and Risk Factors of HPV. [online] Available at: https://www.verywellhealth.com/hpv-causes-risk-factors-3132995.
Carter, J., Koutsky, L., Hughes, J., Lee, S., Kuypers, J., Kiviat, N. and Galloway, D., 2022. Comparison of Human Papillomavirus Types 16, 18, and 6 Capsid Antibody Responses Following Incident Infection.
Nagayasu Egawa, John Doorbar, The low-risk papillomaviruses, Virus Research, Volume 231, 2017, Pages 119-127, ISSN 0168-1702.
Rho, J., Roy-Burman, A., Kim, H., de Villiers, E., Matsukura, T. and Choe, J., (1994). Nucleotide Sequence and Phylogenetic Classification of Human Papillomavirus Type 59. Virology, 203 (1), pp.158-161.
Harro, C., Pang, Y., Roden, R., Hildesheim, A., Wang, Z., Reynolds, M., Mast, T., Robinson, R., Murphy, B., Karron, R., Dillner, J., Schiller, J. and Lowy, D., (2001). Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle Vaccine. JNCI Journal of the National Cancer Institute, 93 (4), pp.284-292.
Hu, Z. and Ma, D., (2018). The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Medicine, 7 (10), pp.5217-5236.
Mayo Clinic (2020, May 22) HPV Test https://www.mayoclinic.org/tests-procedures/hpv-test/about/pac-20394355
Burd, E. (2003). Human papillomavirus and cervical cancer. Clinical Microbiology, 16 (1), 1–17.
Rerucha, C. M., Caro, R. J., & Wheeler, V. L. (2018). Cervical Cancer Screening. American family physician, 97 (7), 441–448.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







